The relationship between 3,4‐methylenedioxymethamphetamine (MDMA) use in young adulthood and anxiety or depressive disorders in the mid‐30s: Findings from the Victorian Adolescent Health Cohort Study
MDMA use (3,4-methylenedioxymethamphetamine or "Ecstasy") in early adulthood appears to be associated with increased odds of anxiety disorders but not depressive disorder by the mid-30s.
Authors
- Kirsten C. Morley (ORCID: https://orcid.org/0000-0002-0868-9928)
- Zachary Bryant (ORCID: https://orcid.org/0000-0002-2115-1516)
- Tim N Slade (ORCID: https://orcid.org/0000-0002-1725-9188)
- Jessica A. Kerr (ORCID: https://orcid.org/0000-0002-3150-4047)
- Craig A. Olsson (ORCID: https://orcid.org/0000-0002-5927-2014)
Institutions
- The University of Sydney (AU)
- Deakin University (AU)
- The University of Melbourne (AU)
- Murdoch Children's Research Institute (AU)
- University of Otago (NZ)
Publication Details
- Journal
- Addiction
- Published
- 2025-08-28
- DOI
- https://doi.org/10.1111/add.70173
- Primary Topic
- Cannabis and Cannabinoid Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Children’s Hospital of Wisconsin Research Institute
- Children's Hospital Foundation
- Murdoch Children's Research Institute
- University of Sydney
- State Government of Victoria
- Medical Research Council
- National Health and Medical Research Council